1. Home
  2. UPST vs AMRX Comparison

UPST vs AMRX Comparison

Compare UPST & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upstart Holdings Inc.

UPST

Upstart Holdings Inc.

HOLD

Current Price

$47.32

Market Cap

4.8B

Sector

Finance

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$12.93

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPST
AMRX
Founded
2012
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.0B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
UPST
AMRX
Price
$47.32
$12.93
Analyst Decision
Buy
Buy
Analyst Count
13
4
Target Price
$59.96
$13.25
AVG Volume (30 Days)
4.9M
1.7M
Earning Date
02-10-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.26
0.02
Revenue
$997,748,000.00
$2,934,959,000.00
Revenue This Year
$56.14
$9.99
Revenue Next Year
$22.99
$6.67
P/E Ratio
$183.61
$691.07
Revenue Growth
64.93
9.50
52 Week Low
$31.40
$6.69
52 Week High
$96.43
$13.49

Technical Indicators

Market Signals
Indicator
UPST
AMRX
Relative Strength Index (RSI) 49.89 58.62
Support Level $43.06 $12.93
Resistance Level $51.53 $13.49
Average True Range (ATR) 2.43 0.29
MACD -0.16 -0.02
Stochastic Oscillator 44.47 52.38

Price Performance

Historical Comparison
UPST
AMRX

About UPST Upstart Holdings Inc.

Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. Upstart's platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small-dollar loans.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: